ObjectiveTo demonstrate the application of causal inference methods to observational data in the obstetrics and gynecology field, particularly causal modeling and semi-parametric estimation.BackgroundHuman immunodeficiency virus (HIV)-positive women are at increased risk for cervical cancer and its treatable precursors. Determining whether potential risk factors such as hormonal contraception are true causes is critical for informing public health strategies as longevity increases among HIV-positive women in developing countries.MethodsWe developed a causal model of the factors related to combined oral contraceptive (COC) use and cervical intraepithelial neoplasia 2 or greater (CIN2+) and modified the model to fit the observed data, drawn from women in a cervical cancer screening program at HIV clinics in Kenya. Assumptions required for substantiation of a causal relationship were assessed. We estimated the population-level association using semi-parametric methods: g-computation, inverse probability of treatment weighting, and targeted maximum likelihood estimation.ResultsWe identified 2 plausible causal paths from COC use to CIN2+: via HPV infection and via increased disease progression. Study data enabled estimation of the latter only with strong assumptions of no unmeasured confounding. Of 2,519 women under 50 screened per protocol, 219 (8.7%) were diagnosed with CIN2+. Marginal modeling suggested a 2.9% (95% confidence interval 0.1%, 6.9%) increase in prevalence of CIN2+ if all women under 50 were exposed to COC; the significance of this association was sensitive to method of estimation and exposure misclassification.ConclusionUse of causal modeling enabled clear representation of the causal relationship of interest and the assumptions required to estimate that relationship from the observed data. Semi-parametric estimation methods provided flexibility and reduced reliance on correct model form. Although selected results suggest an increased prevalence of CIN2+ associated with COC, evidence is insufficient to conclude causality. Priority areas for future studies to better satisfy causal criteria are identified.
oral contraceptives cervical dysplasia hiv, combined oral contraceptive CIN2 risk, hormonal contraception cervical cancer hiv-positive, birth control pills cervical intraepithelial neoplasia, COC and HPV progression, contraceptive pills cervical precancerous lesions, causal inference methods contraception, hormonal contraception cervical disease, cervical cancer screening hiv women, contraceptive pill side effects cervical changes
Cite this article
Patel, S., Mugo, N., Cohen, C., Bukusi, E., Guthrie, B. L., Pfeiffer, R. M., Makhema, J., Parekh, B. S., Piwowar-Manning, E., Hosseinipour, M., Holtz, T. H., Haller, S., Campbell, T. B., Eshleman, S. H., Morrison, C. S., Holmes, K. K., Celum, C., Krakoff, I. H., Kurtzberg, J., . . . Chaturvedi, A. K. (2014). Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods. *PloS one*, *9*(6), e101090. https://doi.org/10.1371/journal.pone.0101090
Patel S, Mugo N, Cohen C, Bukusi E, Guthrie BL, Pfeiffer RM, et al. Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods. PLoS One. 2014;9(6):e101090. doi:10.1371/journal.pone.0101090
Patel, S., et al. "Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods." *PloS one*, vol. 9, no. 6, 2014, pp. e101090.
Background: Aside from human papillomavirus (HPV), the role of other risk factors in cervical cancer such as age, education, parity, sexual partners, smoking and human immunodeficiency virus (HIV) hav...
Yonis H et al., 2025
Open Access
BMJ (Clinical research ed.)
Objective: To evaluate the association between contemporary hormonal contraceptive use and the risk of incident ischaemic stroke and myocardial infarction. Design: Real-world, nationwide, prospective ...
Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side EffectsGeneral OB/GYN > Epidemiology > Prevalence
Background: The combined hormonal contraceptive (CHC) with ethinylestradiol and progestins is the most widely used contraceptive method among young women and is used by millions worldwide. However, un...
Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side EffectsGeneral OB/GYN > Epidemiology > Prevalence
Huang Y et al., 2024
Open Access
Frontiers in endocrinology
Background: Premature ovarian insufficiency/failure (POI/POF) is a significant issue for women of reproductive age. Anti-Müllerian hormone (AMH) is a potential biomarker of ovarian reserve, but its cl...
Contraception/Comparison > FABM vs Hormonal > Side EffectsContraception/Comparison > Side Effects > Hormonal ContraceptionGeneral OB/GYN > Epidemiology > Prevalence